Berberine Treat Metabolic Syndrome in Schizophrenia
Status:
Completed
Trial end date:
2017-12-30
Target enrollment:
Participant gender:
Summary
In early clinical study investigators confirmed that berberine could prevent glucose and
lipid metabolism disorder in schizophrenia, so investigators intend to verify the effect and
safety of berberine in treatment for metabolic syndrome in schizophrenia.